DOI: 10.1128/AAC.01360-18
Article Information
PubMed
Published By
History
- Received June 26, 2018
- Returned for modification July 16, 2018
- Accepted August 20, 2018
- Published online October 24, 2018.
Copyright & Usage
Copyright © 2018 American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (August 27, 2018).
- You are viewing the most recent version of this article.
Author Information
- Sheryl A. Zelenitskya,b,
- Divna Calica,
- Rakesh C. Arorac,d,
- Hilary P. Grocottc,d,
- Ted M. Lakowskia,e,
- Ryan Lillicoa and
- Robert E. Arianoa,b
- aCollege of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada
- bDepartment of Pharmacy, St. Boniface Hospital, Winnipeg, Manitoba, Canada
- cMax Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada
- dCardiac Sciences Program, St. Boniface Hospital, Winnipeg, Manitoba, Canada
- ePharmaceutical Analysis Laboratory, College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada
- Address correspondence to Sheryl A. Zelenitsky, zelenits{at}umanitoba.ca.
Citation Zelenitsky SA, Calic D, Arora RC, Grocott HP, Lakowski TM, Lillico R, Ariano RE. 2018. Antimicrobial prophylaxis for patients undergoing cardiac surgery: intraoperative cefazolin concentrations and sternal wound infections. Antimicrob Agents Chemother 62:e01360-18. https://doi.org/10.1128/AAC.01360-18.
